Screener
Perspective Therapeutics CATX Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Perspective Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Perspective Therapeutics’s 10-Q, filed August 10, 2026. Open the filing →
- Filed
- Aug 10, 2026, 4:34 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342512
FAQ
- What is Perspective Therapeutics's shares (diluted)?
- Perspective Therapeutics (CATX) reported shares (diluted) of 120.7M in Q2 2026.
- How has Perspective Therapeutics's shares (diluted) changed year-over-year?
- Perspective Therapeutics's shares (diluted) increased by 62.5% year-over-year, from 74.2M to 120.7M.
- What is the long-term trend for Perspective Therapeutics's shares (diluted)?
- Over 3 years (2021 to 2025), Perspective Therapeutics's shares (diluted) has grown at a -18.7% compound annual growth rate (CAGR), from 548.1M to 294.7M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Perspective Therapeutics's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude